The milk of human kindness: the story of the Mothers Milk Bank at Austin by Wilson-Clay, Barbara
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
International Breastfeeding Journal
Open Access Commentary
The milk of human kindness: the story of the Mothers Milk Bank at 
Austin
Barbara Wilson-Clay*
Address: BS, IBCLC, Austin Lactation Associates,12710 Burson Drive, Manchaca, Texas, USA
Email: Barbara Wilson-Clay* - bwc@lactnews.com
* Corresponding author    
Abstract
Increased scientific study of human milk and awareness of the special nutritional needs of the
premature infant have stimulated interest in human donor milk banking. Yet only three donor
human milk banks existed in the United States in 1998. Having observed better outcomes in human
milk-fed neonatal intensive care patients, two neonatologists in Austin, Texas, founded The
Mothers Milk Bank at Austin (MMBA). Since opening in 1999, the MMBA has expanded rapidly as
the result of careful planning, innovative procedures, fiscal stability, and widespread community
support. The non-profit organizational structure, diversity and progressive vision of the board of
directors and staff, and creative on-going public relations efforts have contributed to the success
of the project. The MMBA demonstrates a model for 21st century milk banking.
Background
The nutritional superiority and immunological benefits
provided by human milk are widely accepted [1,2]. Cer-
tain populations of high-risk infants may profit even more
from these protections [3-7]. Ideally, own-mother's milk
is provided. There is debate about whether banked human
donor milk confers similar advantages. A systematic
review examined outcomes of preterm infants fed donor
human milk versus infant formula [8]. Meta-analysis indi-
cated that the use of donor human milk was associated
with a significant reduction in the relative risk of develop-
ment of necrotizing enterocolitis (NEC) [8].
Recently, Schanler and colleagues questioned the benefit
of banked human donor milk [9]. However, tables
included in the Schanler study describe a significant
decrease in chronic lung disease in the both own-mothers'
milk and donor milk groups compared to the group
receiving preterm infant formula [10]. Further, although
the small sample size was inadequate to detect statistical
significance, additional data included in the tables indi-
cate that the rate of NEC was six per cent in the mothers
milk and donor milk groups compared to 11 percent in
the preterm infant formula group [10].
While un-pasteurized, own mothers' milk remains the
gold standard, many mothers, particularly those who
have given birth to preterm babies, have difficulty produc-
ing adequate volumes of milk [9,11-13]. In Austin, the
capital of Texas, neonatologists George Sharpe, MD and
Audelio Rivera, MD, observed in their neonatal intensive
care units that human milk-fed infants experienced better
outcomes and shorter hospitalizations. They became
interested in establishing a human donor milk bank in
order to provide human milk to infants whose own moth-
ers were unable to fully nourish them.
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Dr. Sharpe recalls, "I became enamored of the prospect of
not having to treat NEC, one of the worst complications
of the growing premature. A milk bank seemed an essen-
tial thing to do for our babies." Dr. Rivera agrees. "We
started the milk bank to ensure that feedings for preterm
infants would be safe and healthy, resulting in fewer com-
plications." In 1998, doctors Rivera and Sharpe joined
forces to found what would become the fourth US human
donor milk bank, the first such facility to open since 1992.
The ambitious scope of the project makes it a model for
21st century milk banking.
Discussion
History of the project
Rivera and Sharpe held a series of exploratory meetings to
investigate available resources and solicit community sup-
port. Their reputations were crucial to selling the idea of a
new milk bank. Two local lactation consultants, a NICU
nurse, several La Leche League leaders, a hospital chap-
lain, the mother of a preterm infant, and two additional
neonatologists formed a core group. The group adopted
an egalitarian working style, set family-friendly policies,
pledged to support breastfeeding, and developed ethical
guidelines for the project. Further, they agreed to embrace
new technologies and to include a research component to
the project in order to advance the science of human
donor milk banking.
After touring existing milk banks and engaging in helpful
dialog with the Human Milk Bank Association of North
America (HMBANA), the group decided to organize the
Austin milk bank as a community-based, free-standing
facility. This crucial decision resulted from concerns that
over-identification with any single institution would pre-
vent acceptance from competing hospitals and limit wide-
spread community support. Because historical review
suggested that milk banks within existing institutions are
vulnerable to funding cuts during budget crises, an auton-
omous milk bank with a supervising board of directors
was deemed the most stable model for success. Addition-
ally, the founders committed to the principle of non-
profit milk banking in order to protect their ability to pro-
vide donor milk by prescription without regard for recipi-
ents' ability to pay. Once these organizational and
philosophical decisions were made, the group constituted
itself as a Board of Directors (BOD). In 1998, with pro
bono assistance from a generous attorney, the BOD
applied for and was granted status by the US Internal Rev-
enue Service (IRS) as a 501(c)(3) nonprofit organization.
The Mothers Milk Bank at Austin (MMBA) owes much of
its success to the camaraderie and diverse composition of
the BOD, its exceptional staff, and to careful fiscal man-
agement. The project is funded by grants, donations, and,
increasingly, by milk processing fees paid by hospitals
that order supplies of milk for their preterm nurseries. The
healthy financial status of the MMBA allows for expansion
of services and continual up grading of equipment and
methodologies.
The founding neonatologists currently serve as President
and Vice President of the BOD. A vital liaison with the
Austin Blood and Tissue Center was established when
their president consented to serve as the MMBA's treas-
urer. The 21 member BOD meets eight times yearly to
review operations, set policy, and continually reevaluate
program goals. Initially, BOD members performed opera-
tional tasks. Staff now assumes total responsible for the
day-to-day running of the milk bank. Consequently, such
frequent board meetings are not essential. However, the
creative input of the diverse fellowship comprised by the
BOD is felt to be one of the cohesive elements guarantee-
ing the continuing success of the project.
Permanent board seats are designated for a representative
from La Leche League, an IBCLC, and a public member
(either a donor or a mother whose child had been a milk
recipient). Another seat is designated for an ethics advisor.
An Episcopal priest, a rabbi, and a Catholic nun have
served in this capacity. The remaining board seats include
representatives from the insurance, business, high tech,
advertising, legal, arts and entertainment communities.
The diversity of the BOD connects the milk bank project
with funding and publicity resources that might otherwise
not have been available, and provides a flexible mecha-
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nism for accessing valuable consulting expertise at no
cost.
An early task of the MMBA was the creation of an informa-
tional website [14]. In 1999, a community open house
helped familiarize local doctors, health care professionals,
and the Austin community with the milk bank. A series of
publicity events followed involving members of the local
arts and music scene. Several outdoor concerts held annu-
ally on Mothers Day, and fund-raising events held in
nightclubs and coffee houses raised awareness of the value
of human milk and endeared the project to the commu-
nity. While such events generally raised only small
amounts of money (averaging US$5,000.) the publicity
and raised community awareness led to increased private
and corporate donations. Creative public relations strate-
gies continue to attract donations of milk, money, and
assist in recruiting volunteer workers.
In the spring of 1999, the BOD and the project's first Exec-
utive Director, Andrea Morgan, produced a Policies and
Procedures manual, and adopted the milk banking stand-
ards and guidelines of HMBANA. The first milk donors
were screened and approved following the HMBANA
guidelines, (available on the HMBANA website) [15].
Quality control
The MMBA adopted protocols for bacteriological screen-
ing, milk pasteurization, and nutritional labeling that met
or exceeded HMBANA guidelines. Pre-pasteurization milk
samples are drawn and plated for identification and
counting of bacterial colonies. Milk testing positive for
Staphylococcus aureus, methicillin- resistant S. aureus, and
any of the bacillus species are discarded owing to the fact
that endotoxins of these organisms are heat-resistant. Pas-
teurization may not render them harmless [16]. Aseptic
technique is employed throughout the pasteurization
process (see figure 1). Batches of three- and four-ounce
(88–118 ml) bottles of milk are pasteurized using the
long-term low temperature Holder technique, which
holds milk at 62.5 °C for 30 minutes in a shaking water
bath.
Milk samples are drawn and re-tested following pasteuri-
zation. No bacterial growth is tolerated in post-pasteuriza-
tion milk. Pasteurized milk is held in freezers until results
of post-pasteurization bacteriological testing are received.
The milk is approved once pasteurized milk samples show
no growth on 48-hour cultures plated and read by an
independent microbiology laboratory. MMBA staff main-
tains careful records for each batch of processed milk,
including statistics on what percentage of milk is dis-
carded owing to contamination. All bottles and batches
are labeled and numbered to permit tracking.
Pediatrix, a national organization of pediatricians and
neonatologists, donated a Foss Milkoscan to the milk
bank in 2000, allowing for nutritional analysis of pre- and
post-pasteurization human donor milk (see figure 2).
Widely used in the dairy industry, the Milkoscan uses a
full spectrum infrared laser to conduct a nutritional anal-
ysis of the macronutrients found in milk – fat, protein,
and lactose. Currently, no other non-profit US milk bank
is utilizing Milkoscan technology. Calibrating the Milkos-
can for human milk values took MMBA researchers many
months [16]. Eventually, the MMBA was able to dispense
milk labeled with specific calorie and protein values. Dur-
ing the calibration period, the Milkoscan sampling proc-
ess revealed widely varying fat contents in the milk of
donor mothers. While not an issue for their own, thriving
babies, batches of low calorie milk were deemed inade-
quate for the growth needs of preterm infants. By 2003,
the MMBA made the decision to move from random to
target pooling to enable the milk bank to dispense labeled
bottles of 20, 22, or 24-calorie milk.
By the end of 1999, the MMBA processed 10,000 ounces
(296 litres) of milk and was dispensing milk to three hos-
pitals and one infant in the community. By 2000, the staff
grew to include a program director and a program assist-
ant, who supervised all aspects of the donor milk pro-
gram, including pasteurization. The addition of staff
enabled increased enrollment of donors and increased
pasteurization capacity. By the end of 2000, the MMBA
had 148 donor mothers, and was serving six hospitals and
Foss Milkoscan Figure 2
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nine outpatients clients from all over Texas. Over 51,000
ounces (1508 litres) of milk were pasteurized.
Cost of MMBA donor milk
Human donor milk obtained from non-profit milk banks
is not sold. A processing fee is charged to partially recover
the expense of producing the milk. Production costs
include donor screening and blood testing, microbiologi-
cal testing of milk, pasteurization costs, storage costs,
equipment and shipping expenses, staff salaries, and the
expenses of operating the physical plant. Because actual
production costs exceed the processing fees charged,
human donor milk from the MMBA is partially subsidized
by charitable donations and grants. The current process-
ing fee charged for one ounce (28 ml) is US$3.25.
In January 2006, 14 non-hospitalized children were
receiving milk from the MMBA. These recipients included
infants who were discharged from the preterm nursery
unable to tolerate infant formula. Others included older
babies with nutritional handicaps. Approximately one
half of these recipients are termed "charity patients". This
means they pay a token fee or nothing for the milk. The
MMBA absorbs these costs and raises donations from the
community to defray them.
Approximately 90 per cent of MMBA milk recipients are
hospitalized preterm infants. Generally, the cost of the
milk provided to hospitals is recovered in the form of
processing fees. Some milk is paid for by private insur-
ance, and some families pay for all or part of their infant's
supply. In Texas, some of the milk processing fees are paid
for by Medicaid.
Medicaid is a US government-sponsored program that
releases money to the states to help meet the medical
needs of specialized groups of citizens, including low
income families and children in foster care. A special pro-
vision of Medicaid allows preterm infants to be temporar-
ily enrolled as recipients, providing help to families who
would otherwise be overwhelmed by their medical costs.
Rep. Glen Maxey, state representative from the MMBA's
congressional district, successfully sponsored legislation
in 2001 to obtain Medicaid funding to pay for human
donor milk. The inclusion of Medicaid coverage for donor
human milk made it possible to routinely secure donor
milk for a wider variety of clients including hospitalized
preterm infants without private insurance, outpatient
babies with special nutritional needs, and infants in the
Texas foster care system.
Recent history and plans for future expansion
The BOD conducts annual strategic planning sessions to
chart the course for each up-coming year. This encourages
continual evaluation of the goals of the project. The BOD
made an early decision to expand collection centers out-
side of the Austin area in order to keep pace with increas-
ing demands for milk. A milk collection depot was
opened in Houston in 2000, the first of nine collection
sites around the state. Some hospitals in various US cities
that were using MMBA donor milk began exploring the
idea of starting their own milk banks. Since the founding
of the MMBA, one milk bank has re-opened in Delaware,
and four additional US human donor milk banks have
been established in Ohio, Indiana, Iowa, and Ft. Worth,
Texas, each with mentoring assistance from the MMBA.
In 2004, Dr. Rivera presented research on nutritional data
collected at the MMBA to the American Association of
Pediatrics conference in San Francisco. Several on-going
research studies describing growth outcomes of infants
receiving human donor milk await completion and pub-
lication.
Staff members of the MMBA have written a manual enti-
tled Starting a Donor Human Milk Bank: A Practical Guide
[17]. The guide includes a historical and research review
of milk banking. It provides specific suggestions on creat-
ing budgets and by-laws, and addresses a variety of legal
and organizational issues. The manual describes staffing
and equipment requirements, funding resources, and pro-
vides a template for other communities wishing to access
the operational model employed by the Austin project.
In January 2006, the MMBA consisted of a staff of eight,
and a well-organized cadre of volunteers. In addition to
the BOD, an advisory panel of medical doctors and
researchers has been formed, providing an additional
expert consulting body. Year-end figures for 2005 report
that the MMBA dispensed 186,777 ounces (5524 litres) of
milk, routinely supplying milk to 26 hospitals nationally.
The MMBA is outgrowing its current facility, which houses
the staff, three pasteurizers, nine freezers (equipped with
sensors and emergency back-up power sources), a com-
mercial dishwasher, an ice-maker, and a small research
laboratory. The BOD plans to launch a campaign to
acquire funds for a new space. Ideally this will include a
loading dock to better handle deliveries and shipments,
expanded research facilities, and space for new, advanced
pasteurization technologies.
Conclusion
Inquiries and requests for mentoring assistance from Aus-
tralia, Israel, Korea, and numerous American cities suggest
a resurgence of interest in human donor milk banking.
Based on a very successful first six years, the MMBA
believes that the model of a non-profit, community-based
milk bank is viable and sustainable. As new research and
improved technologies provide better mechanisms forPublish with BioMed Central    and   every 
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quality control, less loss of milk nutrients, and permit spe-
cific nutritional labeling, an expanded role in the use of
human donor milk to provide a safety net for infants
seems assured.
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